Patents by Inventor MATTHEW A.J. DUNCTON

MATTHEW A.J. DUNCTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of synthesizing aztreonam derivatives
    Patent number: 11565999
    Abstract: Disclosed herein are aztreonam derivatives, therapeutic methods of using the aztreonam derivatives, and methods of synthesizing aztreonam derivatives. The aztreonam derivatives can be administered orally to provide orally bioavailable aztreonam.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: January 31, 2023
    Assignee: Arixa Pharmaceuticals, Inc.
    Inventors: Eric M. Gordon, Matthew A. J. Duncton, John Freund
  • Derivatives of relebactam and uses thereof
    Patent number: 11180500
    Abstract: Derivatives of relebactam, therapeutic methods of using the derivatives of relebactam, particularly in combination with ?-lactam antibiotics and pharmaceutical compositions thereof are disclosed. The derivatives of relebactam are suitable for oral administration.
    Type: Grant
    Filed: October 1, 2019
    Date of Patent: November 23, 2021
    Assignee: Arixa Pharmaceuticals, Inc.
    Inventors: Eric M. Gordon, Matthew A. J. Duncton, John Freund
  • AZTREONAM DERIVATIVES AND USES THEREOF
    Publication number: 20210009580
    Abstract: Disclosed herein are aztreonam derivatives, therapeutic methods of using the aztreonam derivatives, particularly in combination with ?-lactamase inhibitors, and pharmaceutical compositions thereof. The aztreonam derivatives can be administered orally to provide orally bioavailable aztreonam.
    Type: Application
    Filed: September 18, 2020
    Publication date: January 14, 2021
    Inventors: ERIC M. GORDON, MATTHEW A.J. DUNCTON, JOHN FREUND
  • METHODS OF SYNTHESIZING AZTREONAM DERIVATIVES
    Publication number: 20200339507
    Abstract: Disclosed herein are aztreonam derivatives, therapeutic methods of using the aztreonam derivatives, and methods of synthesizing aztreonam derivatives. The aztreonam derivatives can be administered orally to provide orally bioavailable aztreonam.
    Type: Application
    Filed: April 6, 2020
    Publication date: October 29, 2020
    Applicant: ARIXA PHARMACEUTICALS, INC.
    Inventors: ERIC M. GORDON, MATTHEW A.J. DUNCTON, JOHN FREUND
  • Aztreonam derivatives and uses thereof
    Patent number: 10815228
    Abstract: Disclosed herein are aztreonam derivatives, therapeutic methods of using the aztreonam derivatives, particularly in combination with ?-lactamase inhibitors, and pharmaceutical compositions thereof. The aztreonam derivatives can be administered orally to provide orally bioavailable aztreonam.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: October 27, 2020
    Assignee: ARIXA PHARMACEUTICALS, INC.
    Inventors: Eric M. Gordon, Matthew A. J. Duncton, John Freund
  • DERIVATIVES OF RELEBACTAM AND USES THEREOF
    Publication number: 20200102307
    Abstract: Derivatives of relebactam, therapeutic methods of using the derivatives of relebactam, particularly in combination with ?-lactam antibiotics and pharmaceutical compositions thereof are disclosed. The derivatives of relebactam are suitable for oral administration.
    Type: Application
    Filed: October 1, 2019
    Publication date: April 2, 2020
    Applicant: ARIXA PHARMACEUTICALS, INC.
    Inventors: ERIC M. GORDON, MATTHEW A.J. DUNCTON, JOHN FREUND
  • AZTREONAM DERIVATIVES AND USES THEREOF
    Publication number: 20190211006
    Abstract: Disclosed herein are aztreonam derivatives, therapeutic methods of using the aztreonam derivatives, particularly in combination with ?-lactamase inhibitors, and pharmaceutical compositions thereof. The aztreonam derivatives can be administered orally to provide orally bioavailable aztreonam.
    Type: Application
    Filed: March 12, 2019
    Publication date: July 11, 2019
    Inventors: ERIC M. GORDON, MATTHEW A.J. DUNCTON, JOHN FREUND
  • Aztreonam derivatives and uses thereof
    Patent number: 10280161
    Abstract: Disclosed herein are aztreonam derivatives, therapeutic methods of using the aztreonam derivatives, particularly in combination with ?-lactamase inhibitors, and pharmaceutical compositions thereof. The aztreonam derivatives can be administered orally to provide orally bioavailable aztreonam.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: May 7, 2019
    Assignee: ARIXA PHARMACEUTICALS, INC.
    Inventors: Eric M. Gordon, Matthew A. J. Duncton, John Freund
  • AZTREONAM DERIVATIVES AND USES THEREOF
    Publication number: 20190100516
    Abstract: Disclosed herein are aztreonam derivatives, therapeutic methods of using the aztreonam derivatives, particularly in combination with ?-lactamase inhibitors, and pharmaceutical compositions thereof. The aztreonam derivatives can be administered orally to provide orally bioavailable aztreonam.
    Type: Application
    Filed: October 1, 2018
    Publication date: April 4, 2019
    Inventors: ERIC M. GORDON, MATTHEW A.J. DUNCTON, JOHN FREUND